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 Abstract    
Objectives: Endometriosis is a chronic disease manifested as peritoneal endometrial implants and adhesions, as 
well as endometrial cysts, with pain as the dominant component.
The aim: The aim of the study was to evaluate the role of chemokine (MCP-1, MCP-2, MIP-1 , MIP-1  and RAN-
TES) and non-chemokine (urocortin, ghrelin, and leptin) factors in the intensity of pelvic pain in women with endo-
metrial cysts.  
Material and methods: A total of 86 women, aged 18-38, treated laparoscopically between September 2009 
and November 2012, due to adnexal changes, i.e. endometrial cysts and mature teratomas, were recruited for the 
study. On a numeric rating scale, i.e. PSS (Pain Sensation Scale – according to Johnson), the patients rated pain 
intensity. The level of pain-related stress was investigated with the Pain Distress Scale (PDS, according to Johnson). 
Results: Medians for MCP-1, MCP-2, MIP-1 , MIP-1  and RANTES concentrations were not statistically signiﬁ-
cantly diﬀerent. The respondents rated pain intensity during menses as 6 and 3 points in the E and T groups, re-
spectively (6 vs. 3 points; p=0.001). Statistically signiﬁcant diﬀerences were also observed for pain intensity during 
work (apart from menses), (2 vs. 2 points, p=0,014) and during sexual intercourse (apart from menses) (3 vs. 1 
points, p=0.006). Pain-related stress levels were higher in the T group as compared to the E group (3 vs. 5 points; 
p=0.007). 
Conclusions: It seems safe to conclude that chemokines and leptin may play a signiﬁcant role in the occurrence 
of pain complaints among women with endometrial cysts. Further research might result in implementation of new 
treatment methods for pain management, especially in terms of pharmacotherapy.
 Key words: MCP-1 / MCP-2 / / 	
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 Streszczenie   
Wstęp: Endometrioza jest przewlekłą chorobą, występująca pod postacią wszczepów i zrostów otrzewnowych jak 
również torbieli endometrialnych w przebiegu, której dominuje komponenta bólowa.  
Cel pracy: Celem pracy była ocena wpływu chemokin (MCP-1, MCP-2, MIP-1 , MIP-1  i RANTES) i czynników 
niechemokinowych (urokortyny, greliny i leptyny) na występowanie dolegliwości bólów miednicy mniejszej u kobiet 
z torbielami endometrialnymi.  
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Material and methods                
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Materiał i metody: Badaniem objęto łącznie 86 kobiet, w wieku 18-38 lat, leczonych laparoskopowo, z powodu 
zmian w przydatkach o charakterze torbieli endometrialnych i potworniaków dojrzałych, od września 2009 r. do 
listopada 2012 roku. Na skali intensywności bólu numerycznej (Pain Sensation Scale – PSS, wg. Johnsona) pa-
cjentki zaznaczały odpowiedzi na pytania dotyczące stopnia nasilenia bólu. Badano również poziom stresu (Pain 
Distress Scale – PDS, wg. Johnsona) jaki występuje podczas dolegliwości bólowych.
Wyniki: Mediany MCP-1, MCP-2, MIP-1 , MIP-1  i RANTES, urokortyny, leptyny, greliny nie różniły się istotnie 
statystycznie.  Według respondentek, mediana natężenia bólu, występującego podczas miesiączki, wynosiła 6 pkt. 
w grupie kobiet z torbielami endometrialnymi a u pacjentek z potworniakami 3 pkt. (6 vs 3; p=0,001). Różnice istotne 
statystycznie występowały także dla wartości odpowiadającym natężeniu dolegliwości bólowych, poza miesiączką, 
w pracy zawodowej (2 vs 2pkt., p=0,014) i w trakcie odbywania stosunków płciowych (3 vs 1 pkt., p=0,006). 
Stopień odczuwania stresu z powodu dolegliwości bólowych był wyższy w grupie pacjentek z potworniakami vs 
torbielami (3 vs 5; p=0,007).
Wnioski: Chemokiny oraz leptyna mogą mieć znaczący wpływ na występowanie dolegliwości bólowych u pacjentek 
z torbielami endometrialnymi. Dalsze badania w tym obszarze mogłyby przyczynić się zastosowania nowych metod 
leczenia bólu, zwłaszcza w zakresie farmakoterapii. 
 Słowa kluczowe: MCP-1 / MCP-2 / / 	
/ ból / 
     / torbiel endometrialna / 
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Table I. General characteristics for endometrial cysts (E) and mature teratomas (T) groups. 
E group T group
p
mean±SD (median)
age [years] 30.00±4.60 (31) 27.03±4.52 (26) 0.002*
BMI [kg/m2] 23.00±13.00 (23) 22.70±12.00 (22) 0.396
length of the menstrual cycle [days] 28±6.00 (28) 28±7.00 (28) 0.082
duration of the menstruation 6±2.00 (6) 5±3.00 (5) 0.021
lesion diameter in the right ovary [mm] 49.29±14.91 48.64±15.03 0.876
lesion diameter in the left ovary [mm] 48.13±17.87 44.29±10.92 0.474
*statistical signiﬁcance level for Mann-Whitney test
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- single 26 (54.2) 14 (36.8)
0.153
- married 19 (39.6) 22 (58.0)
- divorced 3 (6.2) 1 (2.6)
- widow 0 1 (2.6)
education
-primary 2 (4.2) 5 (13.2)
<0.001*
- VET 3 (6.2) 3 (7.9)
- secondary 29 (60.4) 2 (5.3)
- higher (B.A.) 3 (6.2) 8 (21.0)
- higher (M.A.) 11 (23.0) 20 (52.6)
place of inhabitance 
[population]
< 5 000 31 (64.6) 18 (47.4)
0.133
- 5 001 – 50 000 7 (14.6) 5 (13.2)
- 50 001 – 100 000 3 (6.2) 4 (10.5)
> 100 001 7 (14.6) 11 (28.9)
smoking 
- no 42 (87.5) 36 (94.7) <0.001*
- yes 6 (12.5) 2 (5.3)
parity
- nullipara 34 (70.8) 20 (52.7)
0.074- primipara 5 (10.4) 11 (28.9)
- secundipara 9 (18.8) 7 (18.4)
miscarriage
- no 46 (95.8) 34 (89.5)
0.082
- yes 2 (4.2) 4 (10.5)
overall health condition
- poor 1 (2) 0 (0)
0.119
- rather good 9 (18.8) 11 (28.9)
- good 31 (64.6) 14 (36.9)
-very good 7 (14.6) 13 (34.2)
gynecological check-up 
- more than 1/year 28 (58.3) 14 (36.9)
0.027*
- once a year 14 (29.2) 13 (34.2)
- once every 2 years 4 (8.3) 11 (28.9)
- seldom 2 (4.2) 0
* statistical signiﬁcance level for chi-square test 
Table III. Comparison of urocortin, leptin, ghrelin levels in blood sera of women with endometrial cysts (E group) and mature teratomas (T group). 
assays group mean ±SD max. min. median p
urocortin
[pg/ml]
E group 252.37 348.77 1228.604 0.145 105.1
0.727
T group 256.03 353.92 1227.27 1.03 120.84
leptin
[pg/ml]
E group 8.06 5.19 22.25 0.11 7.16
0.284
T group 9.82 6.31 20.68 1.52 9.13
ghrelin 
pg/ml]
E group 606.78 261.18 1892.06 180.00 584.33
0.153
T group 627.42 158.50 884.58 185.67 657.82
* statistical signiﬁcance level for Mann-Whitney test
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Table IV. Concentrations of MCP-1, MCP-2, MIP-1 , MIP-1  and RANTES in blood sera of women with endometrial cysts (E group) and mature teratomas (T group). 
assays group mean ±SD max. min. median p
MCP-1
[pg/ml]
E group 124.19 84.01 506.34 38.88 87.17
0.598
T group 128.32 76.10 290.4 52.2 91.92
MCP-2
[pg/ml]
E group 282.72 216.00 1037.14 88.71 235.89
0.204
T group 346.87 213.61 860.58 99.16 262.69
MIP-1   
[pg/ml]
E group 261.61 254.13 1621.78 66.86 185.73
0.483
T group 412.95 488.46 2153.32 82.55 199.59
MIP-1  
[pg/ml]
E group 45.10 79.28 510.49 16.14 20.82
0.091
T group 68.16 139.92 677.41 16.2 21.53
RANTES  
[pg/ml]
E group 31 429.79 26 576.6 99 605.00 12.1 24 886.00
0.428
T group 26 988.72 26 013.58 113 435.00 32.6 17 941.5
* statistical signiﬁcance level for Mann-Whitney test





1. menses 6 3 0.001*
2. everyday tasks, apart from menses 2 1 0.672
3. work, apart from menses 2 2 0.014*
4. sexual intercourse, apart from menses 3 1 0.006*
5. defecation, apart from menses 2 1 0.128
6. pain-related stress 3 5 0.007*
  * p<0.05 statistical signiﬁcance level for Mann-Whitney test
Table VI. Evaluation of pain intensity and stress level in women with endometrial cysts. 
pain during 
menses









0.128 0.0341 0.19 0.311 0.145 0.177 r
0.4 0.84 0.272 0.106 0.395 0.239 p
MIP-1 
[pg/ml]
0.0255 -0.267 0.24 0.464 0.109 0.102 r
0.867 0.11 0.163 0.0131* 0.525 0.497 p*
urocortin  
[pg/ml]
-0.0636 -0.0813 0.156 0.367 -0.141 0.2 r
0.691 0.651 0.389 0.0642 0.431 0.203 p
RANTES  
[pg/ml]
0.082 0.000389 0.00911 -0.00698 0.125 -0.00385 r
0.59 0.997 0.957 0.97 0.465 0.979 p
MCP-1
[pg/ml]
0.275 -0.0553 0.0668 0.0262 -0.0102 -0.00922 r
0.0677 0.744 0.701 0.893 0.951 0.951 P
leptin  
[ng/ml]
-0.273 -0.0519 -0.126 -0.348 -0.00285 -0.387 r
0.0664 0.755 0.46 0.0641 0.986 0.00744* p*
MCP-2
[pg/ml]
0.27 0.359 -0.17 -0.364 -0.0987 -0.0657 r
0.0959 0.0437* 0.359 0.073 0.589 0.685 p*
ghrelin
[pg/ml]
0.181 0.0504 -0.221 -0.222 -0.0912 0.122 r
0.289 0.793 0.256 0.306 0.63 0.47 p
* p<0.05 statistical signiﬁcance level for Spearman correlation test
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Table VII. Evaluation of pain intensity and stress level in women with teratomas. 
Pain during 
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Pain unrelated to menses








-0.24 0.0511 -0.162 0.0696 -0.0066 -0.279 r
0.178 0.787 0.407 0.707 0.972 0.115 p
MIP-1 
[pg/ml]
-0.0153 0.094 -0.0153 0.167 0.124 -0.0349 r
0.932 0.624 0.938 0.374 0.534 0.848 p
Urocortin 
[pg/ml]
0.0385 -0.211 -0.277 -0.268 -0.253 -0.123 r
0.828 0.253 0.144 0.136 0.184 0.485 p
RANTES 
[pg/ml]
0.0689 -0.056 -0.011 -0.0852 -0.0519 -0.0477 r
0.696 0.762 0.954 0.641 0.788 0.786 p
MCP-1
[pg/ml]
-0.191 -0.0288 -0.118 -0.0852 -0.159 -0.0801 r
0.276 0.877 0.538 0.641 0.405 0.65 P
Leptin  
[ng/ml]
0.216 0.242 -0.208 0.237 0.169 -0.178 r
0.218 0.189 0.276 0.189 0.376 0.312 p
MCP-2
[pg/ml]
-0.14 0.214 0.0718 0.17 0.175 0.234 r
0.475 0.27 0.74 0.403 0.389 0.229 p
Ghrelin
[pg/ml]
-0.608 -0.00205 0.0711 -0.345 -0.359 0.213 r
0.00132* 0.99 0.754 0.105 0.0914 0.303 p*
* p<0.05 05 statistical signiﬁcance level for Spearman correlation test
